As of 2025-07-04, the Fair Value of Atea Pharmaceuticals Inc (AVIR) is -40.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.62 USD, the upside of Atea Pharmaceuticals Inc is -1,227.93%.
With the market price of 3.62 USD and our fair value calculation, Atea Pharmaceuticals Inc (AVIR) is not a good investment. Investing in Atea stocks now will result in a potential loss of 1,227.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -10.90 | 121.20 | -115.90 | -136.00 | -168.00 | -61.92 |
| YoY growth | 22.14% | 1,211.93% | -195.63% | -17.34% | -23.53% | 199.51% |
| Market Cap (mil) | 310.23 |
| P/E | |
| Forward P/E |
| EPS | -1.64 |
| Avg earnings growth rate | 199.51% |
| TTM earnings | -139.97 |